Table 2.
Systemic treatment at MBC diagnosis (within 2 months) | |
Yes | 60 (86%) |
No | 10 (14%) |
Metastasis directed treatment at MBC diagnosis (within 2 months) | |
Surgery | 12 (17%) |
SABR | 6 (9%) |
Non-stereotactic radiotherapy | 17 (24%) |
None | 37 (53%) |
Metastasis directed treatment at any time | |
Surgery | 18 (26%) |
SABR | 15 (21%) |
Non-stereotactic radiotherapy | 33 (47%) |
None | 12 (17%) |